Well that solves that: a big placing and a very disappointing 1.3p price tag to boot. So what to do now? 

Condor Gold (CNR) has still to inform its long suffering investors of the enormous opposition it faces on the ground as it tries to develop the La India gold mine in Nicaragua. Perhaps it is because CEO Mark Child knows that his company is acting like fascist bullyboys in the way they deal with poor local peasants. Child's actions probably impress his offshore based asset stripping millionaire mates but in the wider world the mood is changing and robber capitalism is not so cool any more. So what is overpaid and underperforming Mark not telling you?

Few, other than the clowns such as Marcus Stuttard at the LSE, can argue against AIM having delivered absolutely dreadful returns for investors. Since its launch the AIM Index is down by 5.4% (dividends included). The FTSE 100 has doubled over the same period and the FTSE Small Cap Index is 250% ahead. Actually the numbers are even worse. Strip out a handful of massive winners like ASOS and Domino's Pizza and the AIM Index is into double digit losses. But are private investors who have born the brunt of this wealth destruction now getting revenge with spate of attempted boardroom purges? Yes and No.

As I had suggested might happen several times, Nomad Stifel has resigned the Fusionex (FXI) account. It could not wait for the AIM delisting on the 26th. Instead it gave notice after hours yesterday that it was quitting as Nomad and Broker with effect from 5PM today. Hooray.Game over.

Flowgroup (FLOW) has updated following a “successful re-capitalisation of the company”. Hmmm – having commenced 2017 at comfortably above 8p and been above 3p prior to a financing announcement last month, the shares have this month fallen below 1p...

Hello Share Scrimpers. When one suggests a share which becomes a two-bagger plus, there is a bit of a duty to keep readers appraised of developments. That is to examine whether it looks like enough is enough and it's time to consider taking profits. In the case of IQE (IQE) though, this is perhaps not the case.

In seven days time shares in Fusionex (FXI) the drowning in red flags tech company from the Norfolk province of Malaysia will be delisted from the AIM Casino. Yet the shares are up by 55% today at 61.5p. WTF?

Electronics products for the wireless telecoms infrastructure and related markets-focused, Filtronic (FTC) is “pleased to provide” a trading update for its year ended 31st May 2017 – and the shares has responded slightly higher towards 13p...

A “Third Quarter Trading Update” announcement from Plant Impact (PIM). Sounds routine, but the shares are currently more than 12% lower at sub 40p…

The question of a soft or hard Brexit does not lie within UK politics but with the priorities of the EU. The EU’s number one priority is to avoid setting a precedent of successful exits – the UK election result does not change this. What is clear, however, is that Mrs May is no longer in control of the outcome; parliament will decide on whatever deal emerges.

In light of base rate increases in the US, technical analyst Jordan Roy Byrne is getting more cautious on the outlook for gold and precious metals. From a fundamental as well as a TA perspective he explains why in the latest podcast from Palisade Capital.

A “Trading Statement” announcement from Microsaic Systems (MSYS) includes Chairman Eric Yeatman commenting “we are very encouraged with the progress since our 21 March 2017 update, when we introduced our biopharma strategy, specifically around bioprocessing. We are engaging with several of the leading players in the global market for bioprocessing equipment”. However, the statement also includes that “the company now expects its H1 and full year 2017 revenue to be significantly lower than for 2016”. Hmmm…

I have been deeply troubled by the most recent lack of profits warning from AIM listed worthless POS Servision (SEV). My initial view, expressed HERE, is that in not admitting to order slippage from December for almost six months it had committed a massive breach of AIM Rules regarding timely disclosure of price sensitive news. But I fear it may be far worse than that.

Our nominations usually come from LSE.co.uk, ADVFN.co.uk, III.co.uk, and sometimes the FT. But this is the first time that our winner comes from the world of academia. And no, the author is not Tom's sociology lecturing Mrs

The demise of so many Standard Listed companies means that poor Cynical Bear has some big holes in his Sub Standard List X1 squad. But fear not, from God's chosen lands of Northern Ireland here comes Rockpool Acqusitions which will list in early July having raised £1.5 million at 10p.

Hello Share Bottlers. You may, or may not, have noticed that I currently favour insurance companies. And following my own advice for once, I am now sitting on cracking profits on two of the biggest, Legal & General (LGEN) and RSA (RSA). I would still commend both these entities to your further inspection. However, I now turn the spotlight on a smaller, newer and more specialised insurance player.

We're looking for exemplary examples of sheer stupidity from those founts of brilliance; LSE.co.uk, III.co.uk and ADVFN.co.uk. Perhaps if they need a guiding light they might care to look at life inside the basket case that is Jim Mellon's Diabetic Boot Company, as sponsored by most of the other AIM companies Jim runs as Cynical Bear pointed out HERE.  The deadline to post your entries in the comments section below is midnight, Sunday 18 June.

It is five weeks since our last update on the portfolio of seven AIM stocks selected for Marcus Stuttard, the sham sheriff of AIM, to put his money into to show his faith in the system of regulation last September. As you will recall, these were all companies which we had Red Flagged but about which AIM Regulation had done nothing. Last month the losses were 61.7% in about 8 months.

On 25 April this year Optibiotix (OPTI) announced it had delivered a small sale of 100,000 units of its LPDL capsule to Germany's HLH BioPharma Vertriebs GmbH. That must have gone well as we are today told that Optibiotix has signed a three year deal that grants HLH a non-exclusive license to produce, package and commercialise products containing OptiBiotix's cholesterol reducing LPLDL® strain.

Earlier today i showed how Magnolia Petroleum (MAGP) has become a gravy train not just for CEO, not so lovely Rita Whittingham, but for her extended family as well. But when the operations are not generating cash how to fund the gravy train? Shimples: pump the stock with misleading RNS statements and do a discounted placing. Rinse and repeat. Want an example (for there are many)? Here goes.